This QD-Apt (Dox) complex was shown to selectively bind to prostate cancer cells that expressed PSMA on the membrane, and it enhanced the toxicity towards PSMA+ prostate cancer cells [120]. The gene discussed is FOLH1; the disease is prostate carcinoma.